
Rihanna's wealth takes a nearly 30% hit in 2025, and it's not about her music, here's what went wrong
Rihanna's net worth experienced a $400 million decrease in 2025, a 29% drop from the previous year, primarily due to challenges in her Fenty Beauty and Savage X Fenty ventures. A leadership transition at Savage X Fenty and flat sales for Fenty Beauty, particularly in the challenging Chinese market, contributed to this financial downturn.
Tired of too many ads?
Remove Ads
Rihanna's Net Worth Drops
Rihanna Still Hustling And Expanding Her Business
Tired of too many ads?
Remove Ads
FAQs
Rihanna has long been hailed not only as a pop sensation but as a self-made billionaire who diversified her fame into a beauty and fashion empire, as per a report. But in 2025, the singer is experiencing a financial reversal as her net worth has slipped by $400 million, 29% down from her 2024 valuation of $1.4 billion, as per ForbesThe dip in her net worth is not related to her music-related career, but due to her business ventures in Fenty Beauty and Savage X Fenty, according to a Vibe report.Rihanna was ranked number 35 on Forbes' America's Richest Self-Made Women, as per the Vibe report. The report accompanying it cited a number of reasons for the drop in her wealth, reported Vibe. Among them was a leadership transition at Savage X Fenty, her own lingerie company, following the resignation of the brand's CEO in August 2024 to become Victoria's Secret's new leader, as per the Vibe report.Meanwhile, the sales for Fenty Beauty, the beauty company she co-founded with luxury behemoth LVMH, are reportedly estimated to be flat, according to the report. Fenty Beauty was launched in China last year amid what LVMH described as a "challenging environment," reported Vibe.However, even though her wealth has dropped, the singer has been focused on her expanding business ventures, according to the report. Recently, Savage X Fenty started its Bridal Collection in April and has been consistently launching new pieces for customers, reported Vibe. While, Fenty Beauty got back Body Lava luminizers just before summer, launched the Fenty Beauty Experience in Roblox, and debuted a line of mascaras, as per the report.Her Fenty Beauty sales slowed and her Savage X Fenty brand went through a CEO change, both affected business performance.Not at all. She's still actively launching new products and experiences for fans.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
3 hours ago
- Time of India
ICICI sought to acquire HDFC, reveals chairman Deepak Parekh
Former HDFC chairman Deepak Parekh and ICICI Bank chief Chanda Kochhar MUMBAI: Former HDFC chairman Deepak Parekh, in a candid disclosure, said that then ICICI Bank chief Chanda Kochhar had proposed a merger between the two lenders - well before HDFC's eventual reverse merger with its banking subsidiary. During an interaction with Kochhar on her channel, Parekh said: "I remember you talking to me once. I remember it very clearly. It's never been talked about in public, but I'm willing to share it now. You said that ICICI started HDFC. 'Why don't you come back home?' That was your offer." Parekh said he declined the offer, saying "it won't be fair" or "proper with our name and the bank and all". Parekh said the eventual merger with HDFC Bank, completed in July 2023, was driven mainly by regulatory pressure. RBI had classified NBFCs like HDFC, then holding assets over Rs 5 lakh crore, as systemically important, breaching the Rs 50,000-crore threshold. "RBI supported us and they pushed us into it to some extent and they helped us," he said. However, he added that there were "no concessions, no relief, no time, nothing". Describing the day the merger concluded, Parekh called it "a sad day and a happy day". He said, "It's good for the institution. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 180k traders turn to IC Markets for optimum CFD trading conditions IC Markets Sign Up Undo It's good for the country to have large banks. Look at how large Chinese banks are. We have to be bigger, larger in India." Parekh believes that Indian banks must grow through acquisitions to become stronger in future. On broader economic concerns, Parekh cited persistent uncertainty in supply chains, trade policy, and export conditions as top CEO concerns. Calling insurance the "least understood product", Parekh criticised "mis-selling by banks" driven by high upfront commissions. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now


Time of India
4 hours ago
- Time of India
EU bars Chinese firms from most medical device tenders
The European Union will bar Chinese companies from participating in EU public tenders for medical devices worth 60 billion euros or more ($68.9 billion) per year after concluding that EU companies are not given fair access in China. The measure announced by the European Commission on Friday is the first under the EU's International Procurement Instrument , which entered into force in 2022 and is designed to ensure reciprocal market access. The new restrictions are likely to increase tensions with Beijing inflamed by EU tariffs on China-built electric vehicles, Chinese measures against EU brandy and curbs on exports of rare earths that the EU wants resolved by an EU-China summit in July. The Commission said on Friday that it would exclude Chinese companies from EU government purchases above five million euros. An EU official said, guided by figures of Medtech Europe, the EU medical technology market was worth some 150 billion euros in 2023, with public procurement accounting for a 70% share. Contracts of over 5 million euros were only 4% of tenders, but made up some 60% by value, the official said. Successful bids will have to ensure they include no more than 50% of medical devices from China. If there are no alternative suppliers, the exclusion will not apply. EU members backed the plan earlier this month. The Commission has previously said it found "clear evidence" that China favoured Chinese devices for hospitals and its tender conditions led to abnormally low bids that profit-oriented companies could not offer. A Commission official said the ban would cover medical equipment including imaging equipment, artificial body parts and medical clothing. China's commerce ministry has previously described the proposed EU measures as "protectionist", urging the EU to be fair and transparent and for both sides to resolve differences through cooperation and dialogue. The Commission said China had not proposed any corrective action to remedy the situation, but an agreement was still possible.
&w=3840&q=100)

Business Standard
5 hours ago
- Business Standard
Epsilon to challenge China's dominance in EV battery cell materials
May set up ₹9K cr plant for making 100K tonnes of graphite anode Surajeet Das Gupta New Delhi Listen to This Article Rare earth magnet is not the only area where the Chinese dominate the world. They also control two other crucial areas of electric vehicle (EV) battery cell — manufacturing of graphite anode, required for lithium-ion batteries, as well as cathode powder, to make lithium iron phosphate (LiFePO4 or LFP) battery. LFP batteries go into buses and commercial vehicles (CVs), and are considered safer. But an Indian company, Epsilon Advanced Materials, is trying to break into the market. It has finalised plans to set up a plant to manufacture these in Karnataka. To begin with, it is setting up a 100,000